We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Alternative to Open-Heart Surgery in Children

By HospiMedica staff writers
Posted on 28 May 2002
A new device is designed to close holes in children's hearts caused by atrial septal defect without the need for open-heart surgery. More...
The device, called the Amplatzer Septal Occluder, has been cleared by the US Food and Drug Administration (FDA).

The Amplatzer device is placed in the child's heart through a catheter inserted into a vein in the child's leg. Once in the heart, the device's mesh-wire discs are opened on both sides of the hole. The device is unscrewed from the catheter and the catheter is removed from the child's leg, leaving the device covering the hole in the heart. Within three to six months, tissue will grow over the device to permanently seal the hole.

The Amplatzer device is a self-expanding, double-disc device made from Nitinol wire mesh. The two discs are linked by a wire-mesh cylinder that corresponds to the size of the hole in the heart. The device comes in a number of sizes and is filled with polyester fabric to increase its ability to close the hole. Interventional cardiologists at the Texas Children's Hospital (Houston, USA) have successfully implanted the septal occluder in 14 patients.

"When applicable, using the Amplatzer device for children is an excellent alternative to open-heart surgery,” said Dr. Ronald Grifka, director of cardiac catheterization laboratories at Texas Children's Hospital. "The catheterization procedure and device implant are considerably less invasive and less expensive, and the hospital stay and recovery time are decreased dramatically.”




Related Links:
Texas Children's Hosp.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.